Phase I clinical trial - Phases précoces tumeurs solides
EMBER (J2J-MC-JZLA)
Phases précoces tumeurs solides
Essai clinique fermé
Public cible
Adulte
EMBER: A Phase 1a/1b Study of LY3484356 Administered as Monotherapy and in Combination With Anticancer Therapies for Patients With ER+ Locally Advanced or Metastatic Breast Cancer and Other Select Non-Breast Cancers.
Description de l'essai
The reason for this study is to see if the study drug LY3484356 alone or in combination with other anticancer therapies is safe and effective in participants with advanced or metastatic breast cancer or endometrial cancer.
Liens utiles
JEAN-YVES PIERGA
Investigateur principal